The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Open accessAbstract
BACKGROUND: Approximately 20 percent of adults become infected with human papillomavirus type 16 (HPV-16). Although most infections are benign, some progress to anogenital cancer. A vaccine that reduces the incidence of HPV-16 infection may provide important public health benefits. METHODS: In this double-blind study, we randomly assigned 2392 young women (defined as females 16 to 23 years of age) to receive three doses of placebo or HPV-16 virus-like-particle vaccine (40 microg per dose), given at day 0, month 2, and month 6. Genital samples to test for HPV-16 DNA were obtained at enrollment, one month after the third vaccination, and every six months thereafter. Women were referred for colposcopy according to a protocol. Biopsy tissue was evaluated for cervical intraepithelial neoplasia and analyzed for HPV-16 DNA with use of the polymerase chain reaction. The primary end point was persistent HPV-16 infection, defined as the detection of HPV-16 DNA in samples obtained at two or more visits. The primary analysis was limited to women who were negative for HPV-16 DNA and HPV-16 antibodies at enrollment and HPV-16 DNA at month 7. RESULTS: The women were followed for a median of 17.4 months after completing the vaccination regimen. The incidence of persistent HPV-16 infection was 3.8 per 100 woman-years at risk in the placebo group and 0 per 100 woman-years at risk in the vaccine group (100 percent efficacy; 95 percent confidence interval, 90 to 100; P<0.001). All nine cases of HPV-16-related cervical intraepithelial neoplasia occurred among the placebo recipients. CONCLUSIONS: Administration of this HPV-16 vaccine reduced the incidence of both HPV-16 infection and HPV-16-related cervical intraepithelial neoplasia. Immunizing HPV-16-negative women may eventually reduce the incidence of cervical cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
Bauer, H. M. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460040048027 · Cited by 952
Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia
Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachezy, R., Lewis, R., & Romney, S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.18.1365 · Cited by 803
Nobbenhuis, M. A., Walboomers, J. M., Helmerhorst, T. J., Rozendaal, L., Remmink, A. J., Risse, E. K., van der Linden, H. C., Voorhorst, F. J., Kenemans, P., & Meijer, C. J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12490-x · Cited by 685
Suzich, J. A., Ghim, S. J., Palmer-Hill, F. J., White, W. I., Tamura, J. K., Bell, J. A., Newsome, J. A., Jenson, A. B., & Schlegel, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11553 · Cited by 668
Harro, C. D., Pang, Y.-Y. S., Roden, R. B. S., Hildesheim, A., Wang, Z., Reynolds, M. J., Mast, T. C., Robinson, R., Murphy, B. R., Karron, R. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.284 · Cited by 607
Carter, J. J., Koutsky, L. A., Hughes, J. P., Lee, S. K., Kuypers, J., Kiviat, N., & Galloway, D. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315498 · Cited by 575
Self-citationMoscicki, A.-B. (2001) · JAMA · doi:10.1001/jama.285.23.2995 · Cited by 557
Zhou, J., Sun, X. Y., Stenzel, D. J., & Frazer, I. H. (1991) · Virology · doi:10.1016/0042-6822(91)90772-4 · Cited by 506
Wallin, K.-L., Wiklund, F., Ångström, T., Bergman, F., Stendahl, U., Wadell, G., Hallmans, G., & Dillner, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911253412201 · Cited by 493
Kulasingam, S. L., Hughes, J. P., Kiviat, N. B., Mao, C., Weiss, N. S., Kuypers, J. M., & Koutsky, L. A. (2002) · JAMA · doi:10.1001/jama.288.14.1749 · Cited by 452
Self-citation(ALTS) Group, T. A. S. C. O. U. S. /.-G. S. I. L. T. S. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.5.397 · Cited by 438
The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses
Kurman, R. J., & Solomon, D. (1994) · Springer eBooks · doi:10.1007/978-1-4684-0201-8 · Cited by 348
Solomon, D. (1994) · Medical Entomology and Zoology · Cited by 210
Concurrent and Sequential Acquisition of Different Genital Human Papillomavirus Types
Thomas, K. K., Hughes, J. P., Kuypers, J. M., Kiviat, N. B., Lee, S., Adam, D. E., & Koutsky, L. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315805 · Cited by 197
Self-citationzur Hausen, H. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0144 · Cited by 181
Jansen, K. U., Rosolowsky, M., Schultz, L. D., Markus, H. Z., Cook, J. C., Donnelly, J. J., Martinez, D., Ellis, R. W., & Shaw, A. R. (1995) · Vaccine · doi:10.1016/0264-410x(95)00103-8 · Cited by 164
Self-citationBauer, H. M. (1991) · JAMA · doi:10.1001/jama.265.4.472 · Cited by 155
Cassidy, W. M., Watson, B. M., Ioli, V. A., Williams, K., Bird, S. R., & West, D. J. (2001) · PEDIATRICS · doi:10.1542/peds.107.4.626 · Cited by 109
Exact power and sample size for vaccine efficacy studies
Chan, I. S. F., & Bohidar, N. R. (1998) · Communication in Statistics- Theory and Methods · doi:10.1080/03610929808832160 · Cited by 95
Brown, D. R., Bryan, J. T., Schroeder, J. M., Robinson, T. S., Fife, K. H., Wheeler, C. M., Barr, E., Smith, P. R., Chiacchierini, L. M., DiCELLO, A. C., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/323645 · Cited by 79
Self-citationWideroff, L., SCHIFFMAN, M. H., Haderer, P., Armstrong, A., Greer, C. E., Manos, M. M., Burk, R. D., Scott, D. R., Sherman, M. E., Schiller, J. T., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315055 · Cited by 63
Palker, T. J., Monteiro, J. M., Martin, M. M., Kakareka, C., Smith, J. F., Cook, J. C., Joyce, J. G., & Jansen, K. U. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00093-7 · Cited by 58
Self-citationLinglöf, T., van Hattum, J., Kaplan, K. M., Corrigan, J., Duval, I., Jensen, E. H., & Kuter, B. J. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00134-7 · Cited by 22
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007) · PsycEXTRA Dataset · doi:10.1037/e601292007-001 · Cited by 1,882
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
Metadata
- Authors
- Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-11-21
- Volume
- 347
- Issue
- 21
- Pages
- 1645-1651
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2088457548
- Cited by
- 1,602
- References
- 27
- FWCI
- 118.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.